Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Narumi, Taro ^a   Watanabe, Tetsu ^a   Kadowaki, Shinpei ^a   Kinoshita, Daisuke ^a   Yokoyama, Miyuki ^a   Honda, Yuki ^a   Otaki, Yoichiro ^a   Nishiyama, Satoshi ^a   Takahashi, Hiroki ^a   Arimoto, Takanori ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Heart failure; Omentin 1; Prognosis

Indexed keywords

ADIPOCYTOKINE; BRAIN NATRIURETIC PEPTIDE; OMENTIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OMENTIN 1 BLOOD LEVEL; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SUDDEN CARDIAC DEATH; TELEPHONE INTERVIEW; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GPI-LINKED PROTEINS; HEART FAILURE; HUMANS; LECTINS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84899979861     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-84     Document Type: Article

References (37)

1. Jessup M, Brozena S. Heart failure. New Engl J Med 2003, 348(20):2007-2018. 10.1056/NEJMra021498, 12748317.
2. Bradham WS, Ormseth MJ, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM. Insulin Resistance is Associated with Increased Concentrations of NT-proBNP in Rheumatoid Arthritis: IL-6 as a Potential Mediator. Inflammation 2014, DOI:10.1007/s10753-013-9799-4.
3. Mohler ER, Sorensen LC, Ghali JK, Schocken DD, Willis PW, Bowers JA, Cropp AB, Pressler ML. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. J Am Coll Cardiol 1997, 30(1):35-41. 10.1016/S0735-1097(97)00145-9, 9207618.
4. Aispuru GR, Clavier MM, Cardone AJ, Gilberto DO, Barousse AP. Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure. Eur J Intern Med 2012, 23(6):545-551. 10.1016/j.ejim.2012.04.002, 22863433.
5. Kim HM, Lee BW, Song YM, Kim WJ, Chang HJ, Choi DH, Yu HT, Kang E, Cha BS, Lee HC. Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2012, 11(1):84. 10.1186/1475-2840-11-84, 3410768, 22809439.
6. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100(25):2473-2476. 10.1161/01.CIR.100.25.2473, 10604883.
7. von Eynatten M, Schneider JG, Humpert PM, Kreuzer J, Kuecherer H, Katus HA, Nawroth PP, Dugi KA. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol 2006, 47(10):2124-2126. 10.1016/j.jacc.2006.02.033, 16697337.
8. Sun Y, Chen X. Effect of adiponectin on apoptosis: proapoptosis or antiapoptosis?. BioFactors (Oxford, England) 2010, 36(3):179-186.
9. Zhang Y, Wang XL, Zhao J, Wang YJ, Lau WB, Yuan YX, Gao EH, Koch WJ, Ma XL. Adiponectin inhibits oxidative/nitrative stress during myocardial ischemia and reperfusion via PKA signaling. Am J Physiol Endocrinol Metab 2013, 305(12):E1436-1443. 10.1152/ajpendo.00445.2013, 24129398.
10. Agra RM, Teijeira-Fernandez E, Pascual-Figal D, Sanchez-Mas J, Fernandez-Trasancos A, Gonzalez-Juanatey JR, Eiras S. Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients. Eur J Clin Invest 2014, 44(1):29-37. 10.1111/eci.12186, 24117366.
11. Karas MG, Benkeser D, Arnold AM, Bartz TM, Djousse L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, Gottdiener JS, deFilippi CR, Kizer JR. Relations of Plasma Total and High-Molecular-Weight Adiponectin to New-Onset Heart Failure in Adults >/=65 Years of Age (from the Cardiovascular Health Study). Am J Cardiol 2013, 113(2):328-334.
12. Schaffler A, Neumeier M, Herfarth H, Furst A, Scholmerich J, Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005, 1732(1-3):96-102.
13. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006, 290(6):E1253-1261. 10.1152/ajpendo.00572.2004, 16531507.
14. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56(6):1655-1661. 10.2337/db06-1506, 17329619.
15. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008, 57(4):801-808. 10.2337/db07-0990, 18174521.
16. Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 2011, 93(1):21-25. 10.1016/j.diabres.2011.03.001, 21497934.
17. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011, 10:103. 10.1186/1475-2840-10-103, 3235986, 22108456.
18. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011, 219(2):811-814. 10.1016/j.atherosclerosis.2011.08.017, 21925659.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285(26):1441-1446. 10.1056/NEJM197112232852601, 5122894.
20. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119(14):1977-2016.
21. Funayama A, Shishido T, Netsu S, Ishino M, Sasaki T, Katoh S, Takahashi H, Arimoto T, Miyamoto T, Nitobe J, Watanabe T, Kubota I. Serum pregnancy-associated plasma protein a in patients with heart failure. J Card Fail 2011, 17(10):819-826. 10.1016/j.cardfail.2011.05.011, 21962420.
22. Tsuji S, Tsuura Y, Morohoshi T, Shinohara T, Oshita F, Yamada K, Kameda Y, Ohtsu T, Nakamura Y, Miyagi Y. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. Br J Canc 2010, 103(4):517-523.
23. Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, Seya T. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 2001, 276(26):23456-23463. 10.1074/jbc.M103162200, 11313366.
24. Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I. The prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol 2013, 62(5):307-313. 10.1016/j.jjcc.2013.05.007, 23806549.
25. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. discussion 207-112, 10.1002/sim.2929, 17569110.
26. Frankel DS, Vasan RS, D'Agostino RB, Benjamin EJ, Levy D, Wang TJ, Meigs JB. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2009, 53(9):754-762. 10.1016/j.jacc.2008.07.073, 2676793, 19245965.
27. Shimizu I, Yoshida Y, Katsuno T, Tateno K, Okada S, Moriya J, Yokoyama M, Nojima A, Ito T, Zechner R, Komuro I, Kobayashi Y, Minamino T. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell metabolism 2012, 15(1):51-64. 10.1016/j.cmet.2011.12.006, 22225876.
28. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007, 3(12):716-724. 10.1038/ncprheum0674, 18037931.
29. Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin 2012, 8(4):609-617. 10.1016/j.hfc.2012.06.005, 3457065, 22999243.
30. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, Horie M. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 2007, 28(14):1723-1730. 10.1093/eurheartj/ehm154, 17507366.
31. Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S. Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol 2012, 11:151. 10.1186/1475-2840-11-151, 3558365, 23249664.
32. Adeghate E. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem 2008, 15(18):1851-1862. 10.2174/092986708785133004, 18691043.
33. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 2005, 102(30):10610-10615. 10.1073/pnas.0504703102, 1180799, 16030142.
34. Christou GA, Tselepis AD, Kiortsis DN. The metabolic role of retinol binding protein 4: an update. Horm Metab Res 2012, 44(1):6-14.
35. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010, 393(4):668-672. 10.1016/j.bbrc.2010.02.053, 20170632.
36. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011, 408(2):339-343. 10.1016/j.bbrc.2011.04.039, 21514279.
37. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010, 88(1):29-33. 10.1016/j.diabres.2010.01.013, 20129687.